10 Mar 2020
16:30 E.S.T.

US Patent Covering CRISPR-Edited Allogeneic CAR T-Cells Granted to Cellectis

Read more

04 Mar 2020
16:30 E.S.T.

Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2019 Financial Results

Read more

04 Mar 2020
16:05 E.S.T.

Cellectis and Servier Execute the Amendment Confirming the Expansion of their Collaboration on UCART19 Products

Read more

25 Feb 2020
16:30 E.S.T.

Cellectis to Hold Fourth Quarter and Full Year 2019 Earnings Call on Thursday, March 5, 2020 at 7:30 AM EST

Read more

18 Feb 2020
16:30 E.S.T.

Cellectis and Servier Expand Collaboration on UCART19 Products

Read more

15 Jan 2020
16:30 E.S.T.

First Patient Dosed with Cellectis’ New Allogeneic UCART123 Product Candidate for Relapsed/Refractory Acute Myeloid Leukemia

Read more